NiveshIQNiveshIQ
NSE: INNOVACAP

Innova Captab Ltd.

₹969.55▲ ₹0.90 (+0.09%)
Volume: 17,924Day Range: ₹961.05 – ₹983.1552W Range: ₹622.00 – ₹1,034.85
Price Chart  ·  Daily closes
1Y 6M 3M 1M 1W 1D
⚡ Intelligence Signals 5 active
🟢 Bullish Earnings Catalyst 📊 RS Laggard (5D) 🔄 Sector Sweep ⚡ Signals Aligned 📉 Pullback

NiveshIQ has detected 5 active signals on INNOVACAP. Sign up free to see what each signal means and how it affects the stock.

Unlock signals — free
Expected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74 / 100

About Innova Captab Ltd.

Innova Captab Limited is an integrated pharmaceutical company with a core business in research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company generates revenue primarily from the sale of generic formulation products, including cephalosporins, proton pump inhibitors, and other therapeutic segments. Innova Captab's contract development and manufacturing organization services to Indian pharmaceutical companies also contribute significantly to its revenue. Recent developments, including record revenue growth and positive earnings per share (EPS) growth, have caught the attention of analysts. The company's competitive position is strengthened by its diversified product portfolio and expanding global presence. With a revenue of ₹1497

Financial Highlights

MetricFY24FY25FY26
Revenue₹1,081 Cr +16.70%₹1,243 Cr +15.00%₹1,630 Cr +31.10%
EBITDA Margin14.25%15.04%10.61%
Net Profit₹95.00 Cr +39.70%₹128.00 Cr +34.70%₹103.00 Cr -19.50%
EPS₹17.84₹22.42₹17.97

Annual figures in Indian Rupees (Crores). Source: BSE filings.

Analyst ConsensusConsensus target ₹971.50  |  Buy 2 · Hold 0 · Sell 0Sign in to see →

Strategic Outlook

Management commentary highlights product launches, approvals, and therapy-mix improvement as key drivers of near-term gr...

FY26 (last completed FY): revenue ₹1, 630 Cr, PAT ₹103 Cr, EBITDA margin 10.6%, EPS ₹17.97. Year-on-year: revenue YoY +3...

🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instant

Everything you unlock with a free account

Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for INNOVACAP
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track INNOVACAP alongside your other holdings
Unlock full INNOVACAP research — free
No credit card  ·  No trial  ·  Always free to start

Frequently Asked Questions

What AI signals does NiveshIQ provide for Innova Captab Ltd.?

NiveshIQ detects active intelligence signals for Innova Captab Ltd. (INNOVACAP) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.

What are the key financials for Innova Captab Ltd.?

Innova Captab Ltd. is listed on NSE/BSE with a market capitalisation of ₹554,824.3L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.

Does NiveshIQ provide investment advice?

No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.

Viewing preview of Innova Captab Ltd. — 5 active signals detected Unlock full analysis — free